MET vs ORIC · P/E 13, $52.16B cap vs $893.4M cap
MetLife Inc (MET) versus Oric Pharmaceuticals Inc (ORIC) — a side-by-side from cached financials, not a winner call.
MetLife Inc (MET) is a insurance - life company listed on US.
Oric Pharmaceuticals Inc (ORIC) is a biotechnology company listed on NASDAQ.
MET does not have a complete income-statement cache yet.
ORIC does not have a complete income-statement cache yet.
MET currently screens at market cap $52.16B and trailing P/E 12.7. ORIC currently screens at market cap $893.4M.
Not investment advice. Open the MET and ORIC stock pages for the full models.
Not investment advice.